Cigna Is A Buy: Market Overreaction Creates A Big Opportunity
Cigna looks undervalued at under 10x earnings, with strong growth potential. Evernorth continues to expand, adding to the company's long-term value. Large stock buybacks are supporting earnings per...
The Cigna Group Foundation Combats Youth Mental Health Crisis, Now Accepting 2025 Grant Applications from Nonprofits
Nonprofits are encouraged to apply now for 2025 grants The Cigna Group Foundation committed $9 million in 2024 to address youth mental health, distributing $3 million each year through 2026 In firs...
Pacific Prime Dubai Honored Twice at Annual Cigna Healthcare Broker Awards Ceremony
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Pacific Prime Dubai, a leading health insurance and employee benefits brokerage, has made headlines by winning two prestigious awards at the Annual Cig...
Why Cigna Stock Is Plummeting Today
Shares of Cigna (CI -7.49%) were dropping Thursday. The stock was down 8.4% as of 1:20 p.m.
Cigna Q4 Earnings Miss Estimates on Decline in Medical Membership
CI's Q4 results reflect a decline in Individual and Family Plans customers. Management expects 2025 adjusted EPS at a minimum of $29.50, which indicates growth of at least 7.9% from the 2024 figure.
Cigna (CI) Lags Q4 Earnings Estimates
Cigna (CI) came out with quarterly earnings of $6.64 per share, missing the Zacks Consensus Estimate of $7.83 per share. This compares to earnings of $6.79 per share a year ago.
Cigna misses quarterly profit estimates on higher medical costs
Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, hurt by higher medical costs for a type of employer-sponsored healthcare plan.
Cigna: Buy The Drop On This Undervalued Growth Stock
Cigna's current valuation presents a compelling opportunity, trading at a forward PE of 9.9, significantly below its historical average of 12.0x. The company carries diversified revenue streams and...
Raymond James Analysts' Best Picks Could Explode Again in 2025: 4 Red-Hot Dividend Stocks
As the calendar turns to 2025, the leading Wall Street firms are releasing their top stock picks for the new year.
Market Madness: 3 Blue-Chip Dividend Steals You Can't Ignore
The U.S. economy added 256,000 jobs last month, far exceeding expectations, which suggests a strong economy but reduces the likelihood of further Fed rate cuts. Rising long-term rates increase borr...
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Employers are increasingly requiring workers on GLP-1 medications to enroll in nutrition and lifestyle coaching programs. Startup Virta Health saw 60% revenue growth last year, topping $100 million...
The Cigna Group Foundation Supports Mental Health and Housing Stability for Veterans, Announcing First Round of Grant Recipients
BLOOMFIELD, Conn. , Jan. 8, 2025 /PRNewswire/ -- The Cigna Group Foundation announced today 22 recipients for the first year of its new grant program that aims to improve veteran mental health with...
How Cigna Remains at the Top of the Health Insurance Food Chain
The health insurance industry has received a lot of backlash over its managed care practices that bog down providers with pre-authorizations and rampant medical claim denials. The rise in medical b...
Cigna's stock leads selloff among drug middlemen on breakup fears — but this analyst says it's not a real risk
One influential healthcare analyst says the chances of such a bill passing are less than 5%.
Cigna Ends Humana Merger Speculation: CI Jumps 7.3% While HUM Slips
CI reaffirms its 2024 outlook, projecting full-year adjusted EPS to be a minimum of $28.40.
Related Companies